Leadership
Niagen Bioscience unites Nobel laureates, pioneering researchers, global business leaders, and consumer health innovators to advance NAD+ research through precision science and market-leading expertise.
Management
Robert Fried
Chief Executive Officer
Robert Fried drives innovation in healthspan science and wellness, building and leading transformative ventures.
Michiko Kelley
Chief Marketing Officer
Michiko Kelley, a proven marketing leader, drives growth and innovation in consumer and medical tech.
Ozan Pamir
Chief Financial Officer
Ozan Pamir brings expertise in life sciences finance, corporate strategy, capital markets, and funding.
Andrew Shao, Ph.D.
SVP, Global Regulatory & Scientific Affairs
Dr. Andrew Shao is a global expert in nutrition science, regulatory affairs, and health policy reform.
Carlos Lopez
SVP, General Counsel
Carlos Lopez is a legal expert and executive leader in dietary supplements and natural products.
Scientific Advisory Board
Leading minds. Breakthrough science
Charles Brenner, PhD
Chief Scientific Advisor
Dr. Charles Brenner is a noted researcher in NAD+ metabolism, known for discovering the NAD-boosting potential of nicotinamide riboside.
Roger Kornberg, PhD, Nobel Prize Winner
Chairman
Dr. Roger Kornberg, a Stanford professor, won the 2006 Nobel Prize for his work on eukaryotic transcription.
Sir John Walker FRS, FMedSci, Nobel Prize Winner
Member
Sir John Walker won the 1997 Nobel Prize in Chemistry for discovering the mechanism of ATP synthesis.
Dr. Vilhelm (Will) Bohr, M.D., Ph.D., D.Sc.
Member
Dr. Vilhelm Bohr's work has advanced DNA repair, aging, and neurodegenerative disease research.
Brunhilde Felding, Ph.D.
Member
Dr. Brunhilde Felding, a Scripps Research professor, researches breast cancer metastasis and NAD+ metabolism.
Dr. Rudolph Tanzi, PhD
Member
Dr. Rudolph Tanzi, a Harvard neuroscientist, co-discovered key Alzheimer’s genes and advances brain aging research.
Bruce German, PhD
Member
Dr. Bruce German, a UC Davis professor, researches milk science, food structures, and personalized nutrition.
Board of Directors
Visionary leadership. Bold innovation
Robert Fried
Chief Executive Officer
Robert Fried drives innovation in healthspan science and wellness, building and leading transformative ventures.
Frank L. Jaksch Jr.
Co-Founder, Chairman of the Board
Frank L. Jaksch Jr., ChromaDex co-founder, leads research and strategy in pharma and nutraceuticals.
Steven D. Rubin
Non-Executive Director
Steven D. Rubin, a corporate executive and attorney, serves on multiple biotech and healthcare boards.
Wendy Yu
Non-Executive Director
Wendy Yu leads digital strategy and Asia expansion for Horizons Digital Group and its portfolio companies.
Gary Ng
Non-Executive Director
Gary Ng, Project Director at Horizon Ventures, brings retail expertise from leadership roles at AS Watson Group and major brands.
Ann Cohen
Non-Executive Director
Ann Cohen, EVP and CFO of The IIA, has deep expertise in finance, risk management, and accounting.
Kristin Patrick
Non-Executive Director
Kristin Patrick, CMO at Marc Jacobs, brings brand transformation expertise from Gap, Revlon, Pepsi, and leading firms.
Hamed Shahbazi
Non-Executive Director
Hamed Shahbazi, a tech entrepreneur, advances digital health, M&A strategy, and impact investing.
Science Leadership
Andrew Shao, Ph.D.
SVP, Global Regulatory & Scientific Affairs
Dr. Andrew Shao is a global expert in nutrition science, regulatory affairs, and health policy reform.
Mona Rosene, MS, RD
Global Director, Scientific & Medical Affairs
Mona Rosene, MS, RD, is a nutrition expert leading Scientific Affairs at Niagen Bioscience, focusing on cellular health and NAD+ research.
Aron Erickson
VP of Research and Development
Aron Erickson, VP of Research and Development, brings 20 years in chemistry expertise to Niagen Bioscience.
Yasmeen Nkrumah-Elie, PhD
Global Director of External Research at Niagen Bioscience
Dr. Yasmeen Nkrumah-Elie leads global research at Niagen Bioscience, FAMU PhD, NAD+ expert, DEI advocate, Trailblazing Woman awardee.
Erika Shioya
Global Director of Regulatory Affairs
Erika Shioya directs Global Regulatory Affairs at ChromaDex, 15+ years expert, UC Berkeley graduate, sustainability advocate, compliance leader.
Albert Rembert
Vice President of Quality & Product Safety
Albert Rembert leads quality at Niagen Bioscience, 25+ years expert, Navy veteran, Chemical Engineer, drives global compliance.